A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design
Therapeutic Advances in Medical Oncology
Published online on March 11, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Postmenopausal breast cancer survivors treated with neo/adjuvant chemotherapy often experience persistent declines in physical function that fail to resolve after treatment. One mechanism thought to underlie this lasting impairment is cellular ...
Background:Postmenopausal breast cancer survivors treated with neo/adjuvant chemotherapy often experience persistent declines in physical function that fail to resolve after treatment. One mechanism thought to underlie this lasting impairment is cellular ...